Healthcare & Life Science M&A Activity Plummets 1H'22

The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%.

Related Keywords

California ,United States , ,Healthcare Information Technology ,Health It Equities ,Behavioural Health ,Healthcare Service ,Life Sciences ,Health Service Equities ,Healthcare Life Sciences ,Activity Plummets ,Should Know ,Life Science ,Service Equities ,Big Pharma ,Physician Practice Management Sub Sector ,Physician Practice Management ,Physician Fee Schedule ,Relative Value Units ,Acadia Healthcare ,Home Care ,Medicaid Outlook ,Molecular Diagnostics ,Clinical Labs ,Market Key ,